TickerStat.com

Zhengye Biotechnology Holding Ltd (ZYBT)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

4 annual periodsNewest to oldest
2025202420232022
Revenue¥116.4M¥186.4M¥211.7M¥260.3M
Gross profit¥23.9M¥91.3M¥117.5M¥147.9M
Research & development¥18.0M¥12.8M¥11.9M¥13.4M
Operating expenses¥94.4M¥74.9M¥72.5M¥82.0M
Operating income−¥70.5M¥16.4M¥45.0M¥65.8M
EBITDAderived−¥44.6M¥40.6M¥68.9M¥84.6M
Net income−¥69.8M¥11.3M¥31.5M¥46.7M
Basic EPSper diluted share—CN¥0.25CN¥0.69CN¥1.02
Diluted EPSper diluted share—CN¥0.25CN¥0.69CN¥1.02
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗